antifungal/obesidad

El enlace se guarda en el portapapeles.

Elija el tipo de clasificación

Página 1 desde 492 resultados

Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

FIELD OF THE INVENTION The present invention relates to compositions and therapeutic combinations for treating obesity in a subject comprising the administration of sterol and/or 5.alpha.-stanol absorption inhibitor(s) or combinations with obesity control medications. BACKGROUND OF THE

Uses of BT lipopeptides as therapeutics for obesity and related diseases

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

TECHNICAL FIELD The present invention relates in general to the field of biotechnology, more specifically, to use of a family of lipopeptides to treat or prevent obesity and obesity-related diseases including type 2 diabetes mellitus. BACKGROUND Obesity causes a group of serious diseases

Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to a method for treating the metabolic syndrome, obesity, prediabetes or metabolic conditions thereof, or Type 2 diabetes, and more particularly to a method for treating the metabolic syndrome, obesity,

Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

The present invention relates to an agent for reducing the useable calorie content of food. The agent contains a compound that can effect the conversion of fructose to 5-keto-D-fructose. 5-keto-D-fructose cannot be metabolized by the human or animal body and is therefore significantly less caloric

Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION The present invention relates to a series of compounds which are characterised by a 2-[2-(substituted phenyl-oxy, thio or methyl)-1-methylethyl]aminoethanol structure and which have valuable anti-diabetic and anti-obesity activities; in addition, they are capable of

Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND TO THE INVENTION The present invention relates to a series of compounds which are characterised by a 2-[2-(substituted phenyl-oxy, thio or methyl)-1-methylethyl]aminoethanol structure and which have valuable anti-diabetic and anti-obesity activities; in addition, they are capable of

Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

FIELD OF THE INVENTION This invention relates to unacylated ghrelin fragments and analogs thereof as well as to their therapeutic uses. BACKGROUND Ghrelin is a peptide which was isolated from the stomach but is expressed also in many other tissues, including the endocrine pancreas. It was discovered

Prophylactic agent or therapeutic agent for diabetes or obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

TECHNICAL FIELD The present invention relates to a glutamic acid derivative having a CaSR agonist activity or a pharmaceutically acceptable salt thereof as well as a preventive or therapeutic agent for diabetes or obesity comprising as an active ingredient the derivative or a pharmaceutically

Prophylactic or therapeutic agent for diabetes or obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

TECHNICAL FIELD The present invention relates to an alkylamine derivative or a salt thereof, and a pharmaceutical agent comprising the same. More particularly, the present invention relates to a prophylactic or therapeutic agent for diabetes or obesity, which comprises an alkylamine derivative or a

Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase as potential therapeutic agents for obesity and diabetes

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

FIELD OF THE INVENTION The invention relates to inhibitors of ghrelin O-acyltransferase, and methods of making and using them. BACKGROUND The persistent rise in the proportion of overweight individuals in Western society over the past 30 years has been associated with substantial excess morbidity

Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

RELATED APPLICATIONS This is a .sctn.371 of International Application No. PCT/JP2009/063632, with an international filing date of Jul. 31, 2009 (WO 2010/013798 A1, published Feb. 4, 2010), which is based on Japanese Patent Application No. 2008-198047, filed Jul. 31, 2008, the subject matter of which

Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

FIELD OF THE INVENTION The present invention discloses a set of genes which have been demonstrated to be anomalously regulated (i.e., dysregulated) in a model of combining a pathophysiological predisposition towards stroke, hypertension, diabetes and obesity. The present invention also relates to

Composition comprising at least one alginate for use in treatment and/or prevention of overweight

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND The present invention relates to a reconstitutable composition comprising at least one alginate, an aqueous diet preparation comprising said composition and the use of the aqueous diet preparation for the treatment and/or prevention of overweight for both therapeutic and non-therapeutic

Comprehensive pharmacologic therapy for treatment of obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

BACKGROUND OF THE INVENTION Research has identified that long term use of medications for treatment of obesity in patients has resulted in many problems. The two most significant problems encountered by patients using medications to assist in weight loss, assuming the absence of irreversible side

Comprehensive pharmacologic therapy for treatment of obesity

Solo los usuarios registrados pueden traducir artículos

Iniciar sesión Registrarse

REFERENCES Safer than Phen-Fen (copyright 1997), Written by Michael Anchors, MD Ph.D. Pulmonary Vascular Disease, Medical Clinics of North America Nov. 6. 1997, Written by Donald Heath, MD Ph.D. The "Phen-pro" Diet Drug Combination Is Not Associated with Valvular Heart Disease. Jan. 12, 1998

Únete a nuestra
página de facebook

Herbal & Natural Medicine

La base de datos de hierbas medicinales más completa respaldada por la ciencia

Funciona en 55 idiomas
Curas a base de hierbas respaldadas por la ciencia
Reconocimiento de hierbas por imagen
Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
Leer publicaciones científicas relacionadas con su búsqueda
Buscar hierbas medicinales por sus efectos.
Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.